相关实验视频

Updated: May 6, 2026

High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart

High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart

Published on: July 9, 2010

使用无维指数对类风湿性部狭窄症的严重程度的区分及其与结果的关联

Ryan Leow¹, Tony Yi-Wei Li¹, Meei-Wah Chan¹

¹Department of Cardiology, National University Heart Centre Singapore, Singapore.

International journal of cardiology. Cardiovascular risk and prevention

|January 30, 2025

概括

额头 (MV) 的无维指数 (DI) 准确地评估了类风湿性额头狭窄症 (MS) 的严重程度,并预测了不良结果,包括死亡和干预. 这种新方法为识别严重或不严重的MS提供了高特异性.

科学领域:

心脏病学心脏病学
心声回声扫描 (Echocardiography) 是一种心声回声扫描.
膜心脏疾病膜心脏疾病

背景情况:

额头膜狭窄症 (MS) 的严重程度通常通过横胸心声谱 (TTE) 通过额头膜面积 (MVA) 进行评估.
额头 (MV) 的无维指数 (DI) 在退行性多发性硬化症中显示出有前途.
它在风湿性多发性硬化症中的有用性和与临床结果的关联需要评估.

研究的目的:

在患有类风湿性中狭窄症 (MS) 的患者中评估中膜 (MV) 的无维度指数 (DI).
评估DI MV与临床结果之间的关系,包括死亡和中枢干预.

主要方法:

对406名患有类风湿性多发性硬化症的患者进行了回顾性队列研究.
DI MV是通过将左心室外流通道TVI除以MV TVI来计算的.
DI MV与TTE和TEE的MVA测量进行了比较,并分析了其与临床结果的关联.

主要成果:

DI MV准确地分类了MS的严重程度,具有很高的特异性来识别严重的 (DI MV ≤0.25) 和不严重的 (DI MV ≥0.40) MS.
在6.32年的中位数随访中,DI MV与死亡和MV干预的复合结果独立相关.
在MS严重程度的分类中,DI MV曲线下的面积为0.838.

结论:

DI MV 是一个有价值的工具,用于裁决具有高特异性的严重MS.
DI MV与风湿性MS患者的不良临床结果独立相关.
该指数为MS严重程度评估和风险分层提供了一个有希望的替代方案或补充.

关键词:

无维度索引是一个无维度索引.额头骨缩症是什么意思混合关病混合关病.风湿性心脏病是一种心脏病.膜心脏病是一种心脏病.

更多相关视频

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery

Published on: November 28, 2018

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

相关概念视频

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...

Mitral Stenosis I: Introduction

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

Mitral Stenosis IV: Nursing Management

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...